Revenue
2.1 thousand USD
2027 Q1 · USD
Exact inputs and evidence
- Revenue: 2100 USD Source
Market value
$11.04M
4,800,172 shares as of 2026-09-11, at $2.30 a share (HSCS, IEX close on 2026-11-12) Primary-source evidence
Annual consolidated revenue for 2026: about USD 4.319K, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2025, was about USD 4.35K.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-21.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
29906 USD
3904983 shares
71.19% · 1.62 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
4.52 thousand USD
2025-08-01 – 2026-07-31
-10.3 million USD
2025-08-01 – 2026-07-31
-6.79 million USD
2025-08-01 – 2026-07-31
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-19.
Financial data available through: 2026-04-30.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 4,350
–
Current period
USD 4,319
–
4319 − 4350 = -31 USD
4350 USD · 2024-05-01 – 2025-04-30
Inspect prior input Prior source4319 USD · 2025-05-01 – 2026-04-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 8.77 million
–
Current period
−USD 9.14 million
–
-9141875 − -8765229 = -376646 USD
-8765229 USD · 2024-05-01 – 2025-04-30
Inspect prior input Prior source-9141875 USD · 2025-05-01 – 2026-04-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 7.41 million
–
Current period
−USD 7.43 million
–
-7426707 − -7412994 = -13713 USD
-7412994 USD · 2024-05-01 – 2025-04-30
Inspect prior input Prior source-7426707 USD · 2025-05-01 – 2026-04-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 3,157
–
Current period
USD 3,554
–
3554 − 3157 = 397 USD
3157 USD · 2024-05-01 – 2025-04-30
Inspect prior input Prior source3554 USD · 2025-05-01 – 2026-04-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2021 2020-05-01 – 2021-04-30 | 25604 | 2592069 Derived | -2566465 | -114295 Derived | -2452170 | -2453006 Derived | Source
|
| 2022 2021-05-01 – 2022-04-30 | 14373 | 4723772 Derived | -4709399 | 118861 Derived | -4828260 | -3646076 Derived | Source
|
| 2023 2022-05-01 – 2023-04-30 | 5150 | 6118114 Derived | -6112964 | 241326 Derived | -6354290 | -5791885 Derived | Source
|
| 2024 2023-05-01 – 2024-04-30 | 18600 | 6324370 Derived | -6305770 | 299438 Derived | -6605208 | -6134640 Derived | Source
|
| 2025 2024-05-01 – 2025-04-30 | 4350 | 8356921 Derived | -8352571 | 412658 Derived | -8765229 | -7416151 Derived | Source
|
| 2026 2025-05-01 – 2026-04-30 | 4319 | 8417186 Derived | -8412867 | 729008 Derived | -9141875 | -7430261 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Revenue | 25604 |
|
| 2022 | Revenue | 14373 |
|
| 2023 | Revenue | 5150 |
|
| 2024 | Revenue | 18600 |
|
| 2025 | Revenue | 4350 |
|
| 2026 | Revenue | 4319 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | -43.9% |
|
| 2023 | Year over year | -64.2% |
|
| 2024 | Year over year | 261.2% |
|
| 2025 | Year over year | -76.6% |
|
| 2026 | Year over year | -0.7% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Operating margin | -10,023.7% |
|
| 2022 | Operating margin | -32,765.6% |
|
| 2023 | Operating margin | -118,698.3% |
|
| 2024 | Operating margin | -33,902% |
|
| 2025 | Operating margin | -192,013.1% |
|
| 2026 | Operating margin | -194,787.4% |
|
| 2021 | Net margin | -9,577.3% |
|
| 2022 | Net margin | -33,592.6% |
|
| 2023 | Net margin | -123,384.3% |
|
| 2024 | Net margin | -35,511.9% |
|
| 2025 | Net margin | -201,499.5% |
|
| 2026 | Net margin | -211,666.5% |
|
| 2021 | Free cash flow margin | -9,580.6% |
|
| 2022 | Free cash flow margin | -25,367.5% |
|
| 2023 | Free cash flow margin | -112,463.8% |
|
| 2024 | Free cash flow margin | -32,981.9% |
|
| 2025 | Free cash flow margin | -170,486.2% |
|
| 2026 | Free cash flow margin | -172,036.6% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Operating cash flow | -2452294 |
|
| 2022 | Operating cash flow | -3644144 |
|
| 2023 | Operating cash flow | -5773577 |
|
| 2024 | Operating cash flow | -6070185 |
|
| 2025 | Operating cash flow | -7412994 |
|
| 2026 | Operating cash flow | -7426707 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Free cash flow | -2453006 |
|
| 2022 | Free cash flow | -3646076 |
|
| 2023 | Free cash flow | -5791885 |
|
| 2024 | Free cash flow | -6134640 |
|
| 2025 | Free cash flow | -7416151 |
|
| 2026 | Free cash flow | -7430261 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Liabilities / assets | 199.1% |
|
| 2022 | Liabilities / assets | 389.8% |
|
| 2023 | Liabilities / assets | 93% |
|
| 2024 | Liabilities / assets | 23% |
|
| 2025 | Liabilities / assets | 95.1% |
|
| 2026 | Liabilities / assets | 95.7% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Current assets / current liabilities | 1.47× |
|
| 2022 | Current assets / current liabilities | 0.56× |
|
| 2023 | Current assets / current liabilities | 1.47× |
|
| 2024 | Current assets / current liabilities | 4.2× |
|
| 2025 | Current assets / current liabilities | 0.59× |
|
| 2026 | Current assets / current liabilities | 0.53× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2020-05-01 – 2021-04-30 | −USD 2.45 million Exact valueExact value: -2452170 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.45 million Exact valueExact value: -2452294 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 712 Exact valueExact value: 712 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.45 million Calculation and evidence-2452294 − 712 USD Exact free cash flow: -2453006 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2021-05-01 – 2022-04-30 | −USD 4.83 million Exact valueExact value: -4828260 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.64 million Exact valueExact value: -3644144 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1,932 Exact valueExact value: 1932 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.65 million Calculation and evidence-3644144 − 1932 USD Exact free cash flow: -3646076 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2022-05-01 – 2023-04-30 | −USD 6.35 million Exact valueExact value: -6354290 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.77 million Exact valueExact value: -5773577 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 18,308 Exact valueExact value: 18308 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.79 million Calculation and evidence-5773577 − 18308 USD Exact free cash flow: -5791885 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-05-01 – 2024-04-30 | −USD 6.61 million Exact valueExact value: -6605208 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.07 million Exact valueExact value: -6070185 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 64,455 Exact valueExact value: 64455 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.13 million Calculation and evidence-6070185 − 64455 USD Exact free cash flow: -6134640 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2024-05-01 – 2025-04-30 | −USD 8.77 million Exact valueExact value: -8765229 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.41 million Exact valueExact value: -7412994 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3,157 Exact valueExact value: 3157 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.42 million Calculation and evidence-7412994 − 3157 USD Exact free cash flow: -7416151 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2026 2025-05-01 – 2026-04-30 | −USD 9.14 million Exact valueExact value: -9141875 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.43 million Exact valueExact value: -7426707 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3,554 Exact valueExact value: 3554 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.43 million Calculation and evidence-7426707 − 3554 USD Exact free cash flow: -7430261 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
32 filings · 1,311 latest values · 1,311 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001468492, 1468492, HSCS, HSCSW, edgar:1468492
Also known as HEART TEST LABORATORIES, INC., HEARTSCIENCES INC., Heart Test Laboratories, Inc., HeartSciences Inc.